These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9694913)

  • 1. An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors.
    Brimecombe JC; Gallagher MJ; Lynch DR; Aizenman E
    J Pharmacol Exp Ther; 1998 Aug; 286(2):627-34. PubMed ID: 9694913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.
    Brimecombe JC; Potthoff WK; Aizenman E
    J Pharmacol Exp Ther; 1999 Nov; 291(2):785-92. PubMed ID: 10525101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-D-aspartate receptor subunits.
    Boeckman FA; Aizenman E
    J Pharmacol Exp Ther; 1996 Nov; 279(2):515-23. PubMed ID: 8930153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses.
    Mohrmann R; Köhr G; Hatt H; Sprengel R; Gottmann K
    J Neurosci Res; 2002 May; 68(3):265-75. PubMed ID: 12111856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitatory amino acid receptors of the electrosensory system: the NR1/NR2B N-methyl-D-aspartate receptor.
    Harvey-Girard E; Dunn RJ
    J Neurophysiol; 2003 Feb; 89(2):822-32. PubMed ID: 12574460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
    Sharma TA; Reynolds IJ
    J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL; Cordon JJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
    Kew JN; Trube G; Kemp JA
    Br J Pharmacol; 1998 Feb; 123(3):463-72. PubMed ID: 9504387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit.
    Williams K; Chao J; Kashiwagi K; Masuko T; Igarashi K
    Mol Pharmacol; 1996 Oct; 50(4):701-8. PubMed ID: 8863813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro.
    Fischer G; Mutel V; Trube G; Malherbe P; Kew JN; Mohacsi E; Heitz MP; Kemp JA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1285-92. PubMed ID: 9400004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B-specific interactions.
    Gallagher MJ; Huang H; Lynch DR
    J Neurochem; 1998 May; 70(5):2120-8. PubMed ID: 9572299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors.
    Brimecombe JC; Boeckman FA; Aizenman E
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):11019-24. PubMed ID: 9380752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that Xenon does not produce open channel blockade of the NMDA receptor.
    Weigt HU; Adolph O; Georgieff M; Georgieff EM; Föhr KJ
    J Neurophysiol; 2008 Apr; 99(4):1983-7. PubMed ID: 18234987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
    Coughenour LL; Barr BM
    J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits.
    Domingues A; Almeida S; da Cruz e Silva EF; Oliveira CR; Rego AC
    Neurochem Int; 2007 May; 50(6):872-80. PubMed ID: 17403555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
    Zhang XX; Bunney BS; Shi WX
    Synapse; 2000 Jul; 37(1):56-63. PubMed ID: 10842351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.